COVID-19 Acute Respiratory Distress Syndrome
Infectious Diseases
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Sciwind BiosciencesXW001
Alliance PharmaceuticalsProTrans®
Clinical Trials (2)
Total enrollment: 9 patients across 2 trials
Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy
Start: Oct 2021Est. completion: Apr 2022
Phase 2Withdrawn
Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®
Start: May 2021Est. completion: May 20279 patients
Phase 1Active Not Recruiting
Related Jobs in Infectious Diseases
Senior Recruiter
Invivyd
New Haven, CT (Northeast preferred)
5h ago
$120K - $160K/yr
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
8h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
12h ago
$179K - $237K/yr
First Line Sales Leader (Medan)
GSK
Indonesia - Sumatera Utara
Yesterday
General Worker
GSK
Pakistan - Sindh - Karachi
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space